BlackRock’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111K | Sell |
69,851
-2,376
| -3% | -$3.78K | ﹤0.01% | 4747 |
|
|
2025
Q1 | $108K | Hold |
72,227
| – | – | ﹤0.01% | 4703 |
|
|
2024
Q4 | $289K | Sell |
72,227
-2
| -0% | -$8 | ﹤0.01% | 4495 |
|
|
2024
Q3 | $904K | Hold |
72,229
| – | – | ﹤0.01% | 4147 |
|
|
2024
Q2 | $1.05M | Sell |
72,229
-276,831
| -79% | -$4.04M | ﹤0.01% | 4114 |
|
|
2024
Q1 | $7.83M | Buy |
349,060
+10,747
| +3% | +$241K | ﹤0.01% | 3423 |
|
|
2023
Q4 | $6.4M | Buy |
338,313
+26,867
| +9% | +$508K | ﹤0.01% | 3518 |
|
|
2023
Q3 | $5.33M | Sell |
311,446
-11,723
| -4% | -$201K | ﹤0.01% | 3574 |
|
|
2023
Q2 | $9.7M | Buy |
323,169
+229,589
| +245% | +$6.89M | ﹤0.01% | 3363 |
|
|
2023
Q1 | $2.74M | Buy |
93,580
+194
| +0.2% | +$5.68K | ﹤0.01% | 3823 |
|
|
2022
Q4 | $1.84M | Buy |
93,386
+102
| +0.1% | +$2.01K | ﹤0.01% | 4089 |
|
|
2022
Q3 | $2.82M | Sell |
93,284
-608
| -0.6% | -$18.4K | ﹤0.01% | 3936 |
|
|
2022
Q2 | $2.16M | Sell |
93,892
-229,395
| -71% | -$5.28M | ﹤0.01% | 4141 |
|
|
2022
Q1 | $14.5M | Sell |
323,287
-1,843
| -0.6% | -$82.5K | ﹤0.01% | 3300 |
|
|
2021
Q4 | $12.5M | Sell |
325,130
-1,192
| -0.4% | -$45.9K | ﹤0.01% | 3474 |
|
|
2021
Q3 | $16.6M | Buy |
326,322
+1,341
| +0.4% | +$68.1K | ﹤0.01% | 3356 |
|
|
2021
Q2 | $28.3M | Buy |
324,981
+247,835
| +321% | +$21.6M | ﹤0.01% | 3033 |
|
|
2021
Q1 | $3.43M | Buy |
+77,146
| New | +$3.43M | ﹤0.01% | 4040 |
|